Angel Biotechnology warns on 2012 earnings – MarketWatch
By Dr. Matthew Watson
 Proactive Investors UK | Angel Biotechnology warns on 2012 earnings MarketWatch LONDON--Angel Biotechnology Holdings PLC , a biopharmaceutical manufacturing company, Friday warned it anticipates an adverse impact on earnings in the current year as it expects that a contract with TransGenRx Inc. will be delayed. MAIN FACTS: ... Angel Biotechnology warns on full-year earningsBusiness7 Angel earnings warning sends share price downHerald Scotland Angel Biotech sees upturn in volumes despite earnings warningProactive Investors UK Stock Market Wire all 5 news articles » |
Uncategorized
Comments Off on Angel Biotechnology warns on 2012 earnings – MarketWatch |
October 21st, 2012
This author published 6032 posts in this site.Share
Comments are closed.
Personalized Gene Medicine
| Mesenchymal Stem Cells
| Stem Cell Treatment for Multiple Sclerosis
| Stem Cell Treatments
| Board Certified Stem Cell Doctors
| Stem Cell Medicine
| Personalized Stem Cells Therapy
| Stem Cell Therapy TV
| Individual Stem Cell Therapy
| Stem Cell Therapy Updates
| MD Supervised Stem Cell Therapy
| IPS Stem Cell Org
| IPS Stem Cell Net
| Genetic Medicine
| Gene Medicine
| Longevity Medicine
| Immortality Medicine
| Nano Medicine
| Gene Therapy MD
| Individual Gene Therapy
| Affordable Stem Cell Therapy
| Affordable Stem Cells
| Stem Cells Research
| Stem Cell Breaking Research